| John Michael Pagel, MD PHD | |
|
1221 Madison St, Suite 1020, Seattle, WA 98104-3588 | |
| (206) 386-2267 | |
| Not Available |
| Full Name | John Michael Pagel |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 1221 Madison St, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376633222 | NPI | - | NPPES |
| 0231730 | Other | WA | L&I |
| 1376633222 | Medicaid | WA | |
| 2000158 | Other | INTERNAL ID-MOTOR VEHICLE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD00037306 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Michael Pagel, MD PHD Po Box 25608, Salt Lake City, UT 84125-0608 Ph: (206) 568-7043 | John Michael Pagel, MD PHD 1221 Madison St, Suite 1020, Seattle, WA 98104-3588 Ph: (206) 386-2267 |
News Archive
Researchers have developed new reliable open-source software to remove identifiers from patient reports.
Scientists at Helmholtz Zentrum München have now discovered how Epstein-Barr virus (EBV) conceals itself in human cells. A main culprit for its bad visibility by the immune system is the viral protein LMP2A. As published in the scientific journal PLOS Pathogens, the protein helps EBV-infected cells hide from T cells. This camouflage through the LMP2A protein may play a major role in the causation of cancer by EBV.
Verizon Enterprise Solutions, Motorola Mobility Inc. and BoxTone are collaborating to develop a comprehensive mobile solution to help satisfy the unique security, reliability and usability requirements of the health care industry. By providing health care practitioners with secure mobile devices and apps, patient care can be improved through the sharing of clinical data in near-real time to help speed decision making and control costs.
Oramed Pharmaceuticals Inc., a developer of oral delivery systems, announced today that it has successfully completed a comprehensive toxicity study for its flagship oral insulin capsule, ORMD-0801.
› Verified 2 days ago
Sandhya Ramanathan Panch, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-520-5000 | |
Stephen A Lopez, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 925 Seneca St, Seattle, WA 98101 Phone: 206-341-0860 | |
Dr. Susan Hunt, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Uwmc Department Of Medicine, Box 356429, Seattle, WA 98195 Phone: 206-221-7993 Fax: 206-221-8732 | |
Timothy William Menza, MD, PHD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Dr. Vinay Gupta, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-6980 Fax: 206-223-6982 | |
Dr. Maria Ann Corcorran, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-520-5000 | |
Vyshak Alva Venur, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-520-5700 |